• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Beth Wittmer, RN, OCN: How Nurses Are Preparing for Anticancer Biosimilars


Beth Wittmer, RN, OCN, senior manager of care management at Florida Cancer Specialists, addresses how nurses are being educated about biosimilars.


What are practices doing to prepare for the arrival of anticancer biosimilars, and how are nurses in particular being educated?

Well from our practice, we have a very large pharmacy, our own in-house pharmacy Rx to Go. They are preparing by meeting with the pharmaceutical companies and trying to find the best options payable as well as delivering the drug.

Then we work with the pharmacists there who give us education. For our care management department, we rolled that out in webinars to our nurses so that they’re well aware of the side effects and how to manage the patient.

Recent Videos
Jeffrey Casberg, MS, RPh
Jeffrey Casberg, RPh, MS.
Jeffrey Casbery, IPD Analytics
Lakesha Farmer, PharmD
Lakesha Farmer from Cencora
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Related Content
© 2024 MJH Life Sciences

All rights reserved.